CircDIDO1 inhibits gastric cancer progression by encoding a novel DIDO1-529aa protein and regulating PRDX2 protein stability

Abstract Background Circular RNAs (circRNAs) play important roles in cancer development and progression. The purpose of this study is to identify aberrantly expressed circRNAs in gastric cancer (GC), unravel their roles in GC progression, and provide new targets for GC diagnosis and therapy. Methods...

Full description

Bibliographic Details
Main Authors: Yu Zhang, Jiajia Jiang, Jiayin Zhang, Han Shen, Maoye Wang, Zhen Guo, Xueyan Zang, Hui Shi, Jiayan Gao, Hui Cai, Xinjian Fang, Hui Qian, Wenrong Xu, Xu Zhang
Format: Article
Language:English
Published: BMC 2021-08-01
Series:Molecular Cancer
Subjects:
Online Access:https://doi.org/10.1186/s12943-021-01390-y
_version_ 1818903131208024064
author Yu Zhang
Jiajia Jiang
Jiayin Zhang
Han Shen
Maoye Wang
Zhen Guo
Xueyan Zang
Hui Shi
Jiayan Gao
Hui Cai
Xinjian Fang
Hui Qian
Wenrong Xu
Xu Zhang
author_facet Yu Zhang
Jiajia Jiang
Jiayin Zhang
Han Shen
Maoye Wang
Zhen Guo
Xueyan Zang
Hui Shi
Jiayan Gao
Hui Cai
Xinjian Fang
Hui Qian
Wenrong Xu
Xu Zhang
author_sort Yu Zhang
collection DOAJ
description Abstract Background Circular RNAs (circRNAs) play important roles in cancer development and progression. The purpose of this study is to identify aberrantly expressed circRNAs in gastric cancer (GC), unravel their roles in GC progression, and provide new targets for GC diagnosis and therapy. Methods Bioinformatic analyses were performed to identify the aberrantly expression of hsa_circ_0061137 (termed as circDIDO1) in GC. Gain- and loss-of-function studies were performed to examine the biological roles of circDIDO1 in GC progression. Tagged RNA affinity purification, mass spectrometry, immunofluorescence, co-immunoprecipitation, and Western blot were used to identify circRNA-interacting and circRNA-encoded proteins. RNA sequencing, qRT-PCR, and Western blot were performed to analyze circRNA-regulated downstream target genes and signaling pathways. Mouse tumor models were used to analyze the effects of circDIDO1 on GC growth and metastasis. Results CircDIDO1 was transcribed from human DIDO1 (death-inducer obliterator 1) gene and formed by back-splicing of exons 2–6 of the linear transcript. circDIDO1 was down-regulated in GC tissues and its low levels were associated with larger tumor size, distal metastasis, and poor prognosis. CircDIDO1 overexpression inhibited while knockdown promoted GC cell proliferation, migration and invasion. CircDIDO1 overexpression suppressed GC growth and metastasis in mouse tumor models. Mechanistically, circDIDO1 encoded a novel 529aa protein that directly interacted with poly ADP-ribose polymerase 1 (PARP1) and inhibited its activity. CircDIDO1 also specifically bound to peroxiredoxin 2 (PRDX2) and promoted RBX1-mediated ubiquitination and degradation of PRDX2, which led to the inactivation of its downstream signaling pathways. Conclusions CircDIDO1 is a new circRNA that has tumor suppressor function in GC and it may serve as a potential prognostic biomarker and therapeutic target for GC.
first_indexed 2024-12-19T20:46:40Z
format Article
id doaj.art-c6965b2a89ca4a47a816cb0ad5d5e6b6
institution Directory Open Access Journal
issn 1476-4598
language English
last_indexed 2024-12-19T20:46:40Z
publishDate 2021-08-01
publisher BMC
record_format Article
series Molecular Cancer
spelling doaj.art-c6965b2a89ca4a47a816cb0ad5d5e6b62022-12-21T20:06:14ZengBMCMolecular Cancer1476-45982021-08-0120111710.1186/s12943-021-01390-yCircDIDO1 inhibits gastric cancer progression by encoding a novel DIDO1-529aa protein and regulating PRDX2 protein stabilityYu Zhang0Jiajia Jiang1Jiayin Zhang2Han Shen3Maoye Wang4Zhen Guo5Xueyan Zang6Hui Shi7Jiayan Gao8Hui Cai9Xinjian Fang10Hui Qian11Wenrong Xu12Xu Zhang13Aoyang Cancer Institute, Affiliated Aoyang Hospital of Jiangsu UniversityAoyang Cancer Institute, Affiliated Aoyang Hospital of Jiangsu UniversityAoyang Cancer Institute, Affiliated Aoyang Hospital of Jiangsu UniversityJiangsu Key Laboratory of Medical Science and Laboratory Medicine, School of Medicine, Jiangsu UniversityAoyang Cancer Institute, Affiliated Aoyang Hospital of Jiangsu UniversityAoyang Cancer Institute, Affiliated Aoyang Hospital of Jiangsu UniversityAoyang Cancer Institute, Affiliated Aoyang Hospital of Jiangsu UniversityAoyang Cancer Institute, Affiliated Aoyang Hospital of Jiangsu UniversityAoyang Cancer Institute, Affiliated Aoyang Hospital of Jiangsu UniversityKey Laboratory of Molecular Diagnostics and Precision Medicine for Surgical Oncology in Gansu Province, Gansu Hospital of Jiangsu UniversityDepartment of Oncology, Lianyungang Hospital Affiliated To Jiangsu UniversityAoyang Cancer Institute, Affiliated Aoyang Hospital of Jiangsu UniversityAoyang Cancer Institute, Affiliated Aoyang Hospital of Jiangsu UniversityAoyang Cancer Institute, Affiliated Aoyang Hospital of Jiangsu UniversityAbstract Background Circular RNAs (circRNAs) play important roles in cancer development and progression. The purpose of this study is to identify aberrantly expressed circRNAs in gastric cancer (GC), unravel their roles in GC progression, and provide new targets for GC diagnosis and therapy. Methods Bioinformatic analyses were performed to identify the aberrantly expression of hsa_circ_0061137 (termed as circDIDO1) in GC. Gain- and loss-of-function studies were performed to examine the biological roles of circDIDO1 in GC progression. Tagged RNA affinity purification, mass spectrometry, immunofluorescence, co-immunoprecipitation, and Western blot were used to identify circRNA-interacting and circRNA-encoded proteins. RNA sequencing, qRT-PCR, and Western blot were performed to analyze circRNA-regulated downstream target genes and signaling pathways. Mouse tumor models were used to analyze the effects of circDIDO1 on GC growth and metastasis. Results CircDIDO1 was transcribed from human DIDO1 (death-inducer obliterator 1) gene and formed by back-splicing of exons 2–6 of the linear transcript. circDIDO1 was down-regulated in GC tissues and its low levels were associated with larger tumor size, distal metastasis, and poor prognosis. CircDIDO1 overexpression inhibited while knockdown promoted GC cell proliferation, migration and invasion. CircDIDO1 overexpression suppressed GC growth and metastasis in mouse tumor models. Mechanistically, circDIDO1 encoded a novel 529aa protein that directly interacted with poly ADP-ribose polymerase 1 (PARP1) and inhibited its activity. CircDIDO1 also specifically bound to peroxiredoxin 2 (PRDX2) and promoted RBX1-mediated ubiquitination and degradation of PRDX2, which led to the inactivation of its downstream signaling pathways. Conclusions CircDIDO1 is a new circRNA that has tumor suppressor function in GC and it may serve as a potential prognostic biomarker and therapeutic target for GC.https://doi.org/10.1186/s12943-021-01390-yCircRNADIDO1Gastric cancerBiomarkerTarget
spellingShingle Yu Zhang
Jiajia Jiang
Jiayin Zhang
Han Shen
Maoye Wang
Zhen Guo
Xueyan Zang
Hui Shi
Jiayan Gao
Hui Cai
Xinjian Fang
Hui Qian
Wenrong Xu
Xu Zhang
CircDIDO1 inhibits gastric cancer progression by encoding a novel DIDO1-529aa protein and regulating PRDX2 protein stability
Molecular Cancer
CircRNA
DIDO1
Gastric cancer
Biomarker
Target
title CircDIDO1 inhibits gastric cancer progression by encoding a novel DIDO1-529aa protein and regulating PRDX2 protein stability
title_full CircDIDO1 inhibits gastric cancer progression by encoding a novel DIDO1-529aa protein and regulating PRDX2 protein stability
title_fullStr CircDIDO1 inhibits gastric cancer progression by encoding a novel DIDO1-529aa protein and regulating PRDX2 protein stability
title_full_unstemmed CircDIDO1 inhibits gastric cancer progression by encoding a novel DIDO1-529aa protein and regulating PRDX2 protein stability
title_short CircDIDO1 inhibits gastric cancer progression by encoding a novel DIDO1-529aa protein and regulating PRDX2 protein stability
title_sort circdido1 inhibits gastric cancer progression by encoding a novel dido1 529aa protein and regulating prdx2 protein stability
topic CircRNA
DIDO1
Gastric cancer
Biomarker
Target
url https://doi.org/10.1186/s12943-021-01390-y
work_keys_str_mv AT yuzhang circdido1inhibitsgastriccancerprogressionbyencodinganoveldido1529aaproteinandregulatingprdx2proteinstability
AT jiajiajiang circdido1inhibitsgastriccancerprogressionbyencodinganoveldido1529aaproteinandregulatingprdx2proteinstability
AT jiayinzhang circdido1inhibitsgastriccancerprogressionbyencodinganoveldido1529aaproteinandregulatingprdx2proteinstability
AT hanshen circdido1inhibitsgastriccancerprogressionbyencodinganoveldido1529aaproteinandregulatingprdx2proteinstability
AT maoyewang circdido1inhibitsgastriccancerprogressionbyencodinganoveldido1529aaproteinandregulatingprdx2proteinstability
AT zhenguo circdido1inhibitsgastriccancerprogressionbyencodinganoveldido1529aaproteinandregulatingprdx2proteinstability
AT xueyanzang circdido1inhibitsgastriccancerprogressionbyencodinganoveldido1529aaproteinandregulatingprdx2proteinstability
AT huishi circdido1inhibitsgastriccancerprogressionbyencodinganoveldido1529aaproteinandregulatingprdx2proteinstability
AT jiayangao circdido1inhibitsgastriccancerprogressionbyencodinganoveldido1529aaproteinandregulatingprdx2proteinstability
AT huicai circdido1inhibitsgastriccancerprogressionbyencodinganoveldido1529aaproteinandregulatingprdx2proteinstability
AT xinjianfang circdido1inhibitsgastriccancerprogressionbyencodinganoveldido1529aaproteinandregulatingprdx2proteinstability
AT huiqian circdido1inhibitsgastriccancerprogressionbyencodinganoveldido1529aaproteinandregulatingprdx2proteinstability
AT wenrongxu circdido1inhibitsgastriccancerprogressionbyencodinganoveldido1529aaproteinandregulatingprdx2proteinstability
AT xuzhang circdido1inhibitsgastriccancerprogressionbyencodinganoveldido1529aaproteinandregulatingprdx2proteinstability